IMGN779, a Novel CD33-Targeting Antibody-Drug Conjugate with DNA Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML
Kovtun, Yelena, Noordhuis, Paul, Whiteman, Kathleen R., Watkins, Krystal, Jones, Gregory E., Harvey, Lauren, Lai, Katharine C., Portwood, Scott, Adams, Sharlene, Sloss, Callum M., Schuurhuis, Gerrit JLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-1077
Date:
March, 2018
File:
PDF, 2.27 MB
english, 2018